Tominersen in Adults with Manifest Huntington’s Disease-Reference-Cited by-同舟云学术

Tominersen in Adults with Manifest Huntington’s Disease

Published:2023-12-07 Issue:23 Volume:389 Page:2203-2205
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

McColgan Peter,Thobhani Alpa,Boak Lauren,Schobel Scott A.,Nicotra Alessia¹,Palermo Giuseppe²,Trundell Dylan¹,Zhou Julian³,Schlegel Valerie,Sanwald Ducray Patricia,Hawellek David J.,Dorn Jonas,Simillion Cedric,Lindemann Michael,Wheelock Vicki⁴,Durr Alexandra⁵,Anderson Karen E.⁶,Long Jeffrey D.⁷,Wild Edward J.⁸,Landwehrmeyer G. Bernhard⁹,Leavitt Blair R.¹⁰,Tabrizi Sarah J.⁸,Doody Rachelle²

Affiliation:

1. Roche Products, Welwyn Garden City, United Kingdom

2. F. Hoffmann–La Roche, Basel, Switzerland

3. Roche Pharma Product Development China, Shanghai, China

4. University of California, Davis, Davis, CA

5. Paris Brain Institute, Paris, France

6. Georgetown University School of Medicine, Washington, DC

7. University of Iowa Health Care, Iowa City, IA

8. University College London Queen Square Institute of Neurology, London, United Kingdom

9. Ulm University, Ulm, Germany

10. University of British Columbia, Vancouver, BC, Canada

Funder